Up a level |
Gleeson, Mary, Peckitt, Clare, To, Ye Mong, Edwards, Laurice, Oates, Jacqueline, Wotherspoon, Andrew, Attygalle, Ayoma D, Zerizer, Imene, Sharma, Bhupinder, Chua, Sue et al (show 18 more authors)
(2018)
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.
LANCET HAEMATOLOGY, 5 (5).
E190-E200.
Banerjee, Susana ORCID: 0000-0002-8840-7934, Michalarea, Vasiliki ORCID: 0000-0002-3102-3534, Ang, Joo Ern ORCID: 0000-0003-2103-996X, Ingles Garces, Alvaro ORCID: 0000-0002-0073-4237, Biondo, Andrea ORCID: 0000-0003-0599-254X, Funingana, Ionut-Gabriel ORCID: 0000-0002-1197-2652, Little, Martin ORCID: 0000-0003-2592-1570, Ruddle, Ruth ORCID: 0000-0003-0025-8872, Raynaud, Florence ORCID: 0000-0003-0957-6279, Riisnaes, Ruth ORCID: 0000-0002-8924-302X et al (show 19 more authors)
(2022)
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 28 (21).
pp. 4634-4641.